David Rose, D.V.M., Ph.D.

Unknown
email: none

Grants

Integrin Receptor Activation in Breast Cancer 1997 (Cycle III)
Postdoctoral Fellowship 3FB-0164 $71,564


Soluble VCAM-1 binding to a4 integrins is cell type specific, activation-dependent, and disrupted during apoptosis in T cells
  Periodical: Blood
  Author(s): Rose DM, Cardarelli PM, Cobb RR, and Ginsberg MH
  Yr: 2000 Vol: 95 Nbr: 2 Pgs: 602-609
  Associated Grant: Integrin Receptor Activation in Breast Cancer
 
Binding of the Paxillin to the x4 integrin modiefies integrin-dependent biological responses
  Periodical: Nature
  Author(s): Liu S, Thomas SM, Woodside DG, Rose DM, Kiosses WB, Pfaff M, Ginsberg MH
  Yr: 1999 Vol: 402 Nbr: Pgs: 676-681
  Associated Grant: Integrin Receptor Activation in Breast Cancer
 
Integrins in the immune system
  Periodical: Advances in Immunology
  Author(s): Shimizu Y, Rose DM, and Ginsberg MH
  Yr: 1999 Vol: 72 Nbr: Pgs: 325-380
  Associated Grant: Integrin Receptor Activation in Breast Cancer